SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-302109
Filing Date
2023-12-22
Accepted
2023-12-22 16:06:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d583842d424b3.htm 424B3 126934
2 GRAPHIC g583842g76c08.jpg GRAPHIC 63177
  Complete submission text file 0001193125-23-302109.txt   215182
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-275958 | Film No.: 231509817
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)